Y Intercept Hong Kong Ltd increased its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 143.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 13,178 shares of the semiconductor company’s stock after purchasing an additional 7,757 shares during the period. Synopsys comprises about 0.4% of Y Intercept Hong Kong Ltd’s investment portfolio, making the stock its 23rd biggest holding. Y Intercept Hong Kong Ltd’s holdings in Synopsys were worth $6,396,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Hazlett Burt & Watson Inc. boosted its position in shares of Synopsys by 40.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after buying an additional 20 shares during the period. Caprock Group LLC grew its stake in Synopsys by 0.5% during the 4th quarter. Caprock Group LLC now owns 3,714 shares of the semiconductor company’s stock valued at $1,803,000 after acquiring an additional 20 shares in the last quarter. Compagnie Lombard Odier SCmA increased its holdings in shares of Synopsys by 1.1% in the 4th quarter. Compagnie Lombard Odier SCmA now owns 1,850 shares of the semiconductor company’s stock valued at $898,000 after purchasing an additional 20 shares during the period. Aptus Capital Advisors LLC lifted its position in shares of Synopsys by 1.5% in the third quarter. Aptus Capital Advisors LLC now owns 1,447 shares of the semiconductor company’s stock worth $733,000 after purchasing an additional 22 shares in the last quarter. Finally, Resurgent Financial Advisors LLC lifted its position in shares of Synopsys by 2.8% in the third quarter. Resurgent Financial Advisors LLC now owns 809 shares of the semiconductor company’s stock worth $410,000 after purchasing an additional 22 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on SNPS shares. Piper Sandler lowered their price objective on shares of Synopsys from $670.00 to $655.00 and set an “overweight” rating on the stock in a research report on Friday, December 6th. Needham & Company LLC restated a “buy” rating and set a $640.00 price target on shares of Synopsys in a report on Thursday, December 5th. Robert W. Baird cut their price objective on Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Redburn Atlantic assumed coverage on Synopsys in a research note on Monday, January 13th. They issued a “buy” rating and a $600.00 target price on the stock. Finally, Rosenblatt Securities reaffirmed a “buy” rating and issued a $635.00 target price on shares of Synopsys in a research report on Wednesday, December 4th. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $641.82.
Insider Activity
In related news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the transaction, the executive now directly owns 1,460 shares in the company, valued at approximately $738,774.60. This trade represents a 93.45 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.66% of the company’s stock.
Synopsys Stock Performance
SNPS opened at $474.84 on Monday. The company has a market cap of $73.40 billion, a PE ratio of 32.70, a price-to-earnings-growth ratio of 3.23 and a beta of 1.12. The stock has a 50-day moving average of $510.21 and a 200-day moving average of $517.67. Synopsys, Inc. has a 52-week low of $457.52 and a 52-week high of $629.38.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
- Five stocks we like better than Synopsys
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- The Significance of Brokerage Rankings in Stock Selection
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Investing in Commodities: What Are They? How to Invest in Them
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.